The compound has not been subjected for the rigorous clinical testing needed for acceptance by regulatory bodies like the FDA, which implies its basic safety and usefulness in treating health care circumstances remain unproven.Nociceptive Pathways: Exploration implies that conolidine may well influence nociceptive pathways, pathways that carry pain